Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Guides
Microarray
Different kinds of biological assays are called microarrays. They include: - DNA microarrays, such as cDNA microarrays and oligonucleotide microarrays - MMChips, for surveillance of microRNA populations - Protein microarrays - Tissue microarrays - Transfection microarrays (also called cell microarrays) - Chemical compound microarrays - Antibody microarrays - Gene chip analysis The links shown on this page feature the key word ′Microarrays’ in their stories:
US laboratory takes sequencing and microarray equipment
Illumina will supply LabCorp with sequencing and microarray equipment for use in laboratory testing to support north American clinics
Life Technologies launches industry's first end-to-end sequencing solution for human exome CVN analysis
Life Technologies launches the first end-to-end sequencing solution for exon-level copy number variation (CNV) analysis, which combines the Ion Reporter CNV data analysis workflow, the Ion AmpliSeq Exome Kit and the Ion Proton System.
PerkinElmer introduces first early onset preeclampsia screening test in the USA
PerkinElmer introduces the first available early onset preeclampsia screening test in the USA.
Sequenom collaborates with CombiMatrix to market chromosomal microarray analysis for prenatal testing
The Sequenom Center for Molecular Medicine (Sequenom CMM) and CombiMatrix are entering into a collaboration agreement to market chromosomal microarray analysis (CMA) testing services to broaden and confirm the results of noninvasive, prenatal testing (NIPT) to physicians and their patients.
Life Technologies launches next generation of analytics power tools for cancer researchers
Life Technologies is introducing Oncomine Next Gen Sequencing Power Tools, an analytics offering that will allow cancer researchers to explore results from in-depth analysis of next generation sequencing (NGS) data, including data from The Cancer Genome Atlas.
SQI Diagnostics launches new multiplexing system for clinical diagnostics
SQI Diagnostics is launching the company's SQiDlite Multiplexing System at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition taking place in Chicago Illinois, USA, October 1 to 18, 2012.
Almac launches Next Generation Sequencing service for personalised medicine
Almac is launching a Next Generation Sequencing service to further expand its range of solutions supporting the development of personalised medicine.
Affymetrix launches RNA amplification technology for whole-genome expression analysis
Affymetrix is introducing SensationPlus FFPE Amplification and 3' IVT Labeling Kit (SensationPlus FFPE Reagent Kit), consisting of RNA amplification and labeling modules, to enable gene expression profiling of formalin-fixed, paraffin-embedded (FFPE) samples on GeneChip 3' IVT arrays and Almac Xcel
Affymetrix collaborates with MGH to develop new oncology biomarkers
Affymetrix is making a research collaboration and licensing agreement with Massachusetts General Hospital (MGH) to co-develop new cancer biomarker tests using the Affymetrix' QuantiGene ViewRNA Assay platform, an in situ hybridization assay capable of single transcript in single-cell detection.
Agendia launches gene expression profile colon cancer
Agendia is launching the company's ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery.
Affymetrix partners ScreenCell for circulating tumour cell technology
Affymetrix and ScreenCell, a privately-held company, are signing a worldwide distribution agreement for ScreenCell's isolation devices and dilution buffers, designed for the collection of Circulating Tumour Cells (CTCs) in peripheral blood.
Almac signs global distribution deal with Affymetrix
Almac signs an exclusive global distribution deal with Affymetrix enabling the company to directly sell Almac's proprietary Xcel array for biomarker discovery, development and delivery worldwide.
China clears the first microarray platform for in vitro diagnostics
Affymetrix's GeneChip System 3000Dx v.2 (GCS 3000Dx v.2) is approved by China's State Food and Drug Administration (SFDA) for in vitro diagnostic use.
SQI Diagnostics signs up Integrated Sciences in Australia
SQI Diagnostics is entering into an agreement with Integrated Sciences, of Australia governing the exclusive marketing, sales and distribution of SQI Diagnostics' IVD products in the Australian marketplace.
Rujin Hospital validates new risk loci for Graves' disease
China's Rujin Hospital in Shanghai is using Fluidigm's integrated fluidic circuits (IFCs) to help validate two new susceptibility loci for Graves' disease.
Astra Biotech releases new microarray-on-a-chip test for cystic fibrosis
Astra Biotech is in the pre-launch phase of the company's newly developed test, based on microarray technology, for rapid simultaneous detection of 25 of the most common mutations causing cystic fibrosis in pan-European populations.
PGXL Labs partners AutoGenomics to develop new pharmacogenetics tests
PGXL Labs is establishing a collaborative partnership with AutoGenomics which will utilise the automated INFINITI analyzer for several different personalized medicine applications.
Arrayjet introduces custom microarray services
Arrayjet is launching custom microarray services to meet the needs of a broader selection of customers.
Caliper Life Sciences develops automation protocols for Illumina kits
Caliper Life Sciences is developing and optimising automation protocols on its Sciclone NGS Workstation for Illumina's TruSeq DNA and TruSeq RNA sample preparation kits.
Affymetrix signs a microarray distribution deal with Fisher Scientific
Affymetrix signs a distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific, to distribute the GeneAtlas System and its related consumables through the Fisher Scientific channel throughout the United States and Canada.
Astra Biotech showcases assays for allergies and hormonal dysfunctions
Berlin-based Astra Biotech is a new company whose core focus is the development of innovative diagnostics for the identification of an individual’s predisposition to disease and will be showcasing at Medica 2010 in Dusseldorf, Germany (Hall 03/G54) the company’s current portfolio of assa
Roche Diagnostics partners CapitalBio to develop molecular diagnostic solutions
Roche Diagnostics and CapitalBio plan to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide.
Microarray platform simplifies analysis of chromosomal copy number changes
Agilent Technologies is introducing the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations.
KTH Royal Institute of Technology invests in new inkjet microarray system
The KTH Royal Institute of Technology in Stockholm, selects Arrayjet’s Marathon Inkjet Microarrayer for its Protein Array Technologies Group.
Myconostica presents positive data from study of MycAssay Pneumocystis
Myconostica is presenting positive data from a multi-centre prospective evaluation of MycAssay Pneumocystis, the company's CE marked diagnostic product for detection of Pneumocystis DNA in respiratory samples.
Illumina starts shipping DNA analysis beadChip to enhance genome coverage
Illumina is beginning to ship its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5) which is a microarray contains millions of newly discovered genome-wide common and rare variants from the 1,000 Genomes Project (1kGP), selected to maximise its ability to detect new associations.
Illumina begins shipping microarray analysis sequencer
Illumina begins shipping HiScanSQ, the first instrument to integrate microarray analysis and next-generation sequencing in a modular design that can evolve with changing research needs.
PerkinElmer prepares to acquire Signature Genomic Laboratories
PerkinElmer is entering into a definitive agreement to acquire Signature Genomic Laboratories, a diagnostic genetic testing company based in Spokane, Washington, USA.
Febit releases 58 new miRNA sequences for cancer research
febit’s updated Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 is now available for cancer research.
Agilent releases the next-generation sequencing platform
Agilent Technologies introduces its Agilent SureSelect Target Enrichment System which supports multiplexed DNA sequencing of 12 to 16 samples per lane depending on the next-generation sequencing platform, reducing costs and increasing throughput up to 16-fold.
New chips with rare variants to drive growth in SNP market
Market analyst, Kalorama Information, suggests that a setback in the scientific basis for SNP (single nucleotide polymorphisms) analysis may turn out to be a blessing in disguise for makers of genotyping equipment, reagents and software.
New sequencing system provides lower-priced entry point
Illumina introduces the Genome AnalyzerIIe sequencing system, designed to provide a lower-priced entry point into next-generation sequencing.
Ipsogen unveils genomic test to identify endocrine-responsive tumours
Ipsogen is launching the MapQuant Dx HR test in Europe.
Quest makes microarray-based aCGH postnatal test available in New York
Quest Diagnostics’ ClariSure microarray-based comparative genomic hybridization (aCGH) postnatal test is now available for testing on patients in the state of New York in the USA.
DIAGNOSTICS – TESTING REVIEW
FOCUS ZONE REPORT – The diagnostic testing sector is almost a constant blur of activity with new technology developments and deals being announced on a daily basis. Here we round-up some of the significant highlights from the past few months.
Agilent unveils new tool streamlining DNA-sequencing research
Agilent Technologies has introduced the Agilent SureSelect Target Enrichment System, a tool for streamlining DNA-sequencing research by enabling the sequencing of only genomic areas of interest with next-generation sequencing instrumentation.
Caliper launches automation solution for molecular biology applications
Caliper Life Sciences has launched the Zephyr Genomics Workstation (GW), an easy-to-use, automation solution for molecular biology applications.
Pathwork Diagnostics launches additional Tissue of Origin Test
Pathwork Diagnostics has launched an additional version of the Pathwork Tissue of Origin Test that has the capability of analysing formalin-fixed, paraffin-embedded (FFPE) tissue specimens.
Agilent releases new online microarray design tool to custom microRNA microarrays
Agilent Technologies has released its eArray 5.4 online microarray design tool, which enables users to design custom microRNA (miRNA) microarrays.
Breast cancer tumour recurrence test identifies risk potential of patients
Dr Michael Knauer from the Netherlands Cancer Institute has announced data uncovering a substantial group of traditionally miscategorised low risk HER2+ patients.
Illumina unveils primary analysis software program to analyse microarray and sequencing data
Illumina has introduced GenomeStudio Software, a primary analysis software program designed to analyse both microarray and sequencing data.
Illumina introduces full-length, cDNA sequencing on the Genome Analyzer
Illumina has announced the broad availability of mRNA-Seq, a new product for full-length, complementary DNA (cDNA) sequencing on the Genome Analyzer.
New instrument automates cancer protein analysis
A new instrument has been demonstrated by a team of scientists led by Cambridge Research and Instrumentation, (CRi), in Woburn, Massachusetts, USA, that makes it possible to detect and quantify multiple clinically important proteins in a single tumour sample using conventional staining.
Agilent unveils next generation gene expression bioinformatics platform
Agilent Technologies has introduced Agilent GeneSpring GX 10.0, the next generation of the company's flagship gene expression bioinformatics platform.
TGen collaborates with febit to evaluate next generation sequencing equipment
febit and the Translational Genomics Research Institute (TGen) is collaborating with TGen to evaluate next generation sequencing equipment in conjunction with febit's proprietary Geniom Microarray Technol
Olympus unveils enhanced dotSlide digital virtual microscopy systems
A new release of the Olympus range of dotSlide digital virtual microscopy systems offers enhanced functionality and image quality for scanning entire slides at high resolution and fidelity, making them accessible and fully navigable, anywhere on the globe.
Caliper unveils two microfluidics-based separations systems for genomics
Caliper Life Sciences has introduced two microfluidics-based separations products, the LabChip GX and LabChip GXII benchtop systems, for fast, automated, 1-D electrophoretic separations of protein, DNA, and RNA samples.
New DNA microarray scanner offer rapid scanning times
Agilent Technologies has unveiled the latest version of the company’s popular Agilent DNA Microarray Scanner, employing SureScan High Resolution Technology to deliver high resolution and rapid scan
febit receives US patent for new microfluidic microarray DNA extraction method
febit has received a US patent on its microfluidic microarray-based method for extraction of DNA and RNA.
New inkjet microarray system offers high-speed production benefits
Arrayjet has released the new Ultra-Marathon Inkjet Microarrayer which is based on the same robust platform as its predecessors, the Marathon and Super-Marathon Inkjet Microarrayers.
First | Prev  | 1 | 2  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo